GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
Sen. Bill Cassidy, chair of the Senate HELP Committee, and ranking member Bernie Sanders were aligned on their concerns about Kennedy's approach to vaccines. With a vote on Kennedy’s nomination to ...
Autoimmune hepatitis recurs after transplantation in ... and for 3 months after, drug withdrawal to detect relapse. Repeat laboratory assessments thereafter at 6–month intervals, then every ...
Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel. [1 ...
Robert F. Kennedy, President Trump’s nominee for health secretary, vigorously defended his views on vaccines, and a key senator still has clear doubts.
In severe cases, the illness can lead to unconsciousness. Hepatitis can be caused not only by viruses and drug use but also by conditions in which the body’s immune system destroys liver cells.